These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1762854)

  • 1. [A pharmacokinetic basis for schedules for administering amikacin to newborn infants].
    Firsov AA; Sudilovskaia NN; Strachunskiĭ LS
    Pediatriia; 1991; (8):33-8. PubMed ID: 1762854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adaptation of amikacin dosages for the premature infant].
    Palix C; Charbit-Bues M; Coignet J; Cano JP
    Pediatrie; 1986 Mar; 41(2):147-57. PubMed ID: 3774426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of chronologic age on the serum concentrations of amikacin in sick term and premature infants.
    Prober CG; Yeager AS; Arvin AM
    J Pediatr; 1981 Apr; 98(4):636-40. PubMed ID: 7205495
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of amikacin in neonates.
    Padovani EM; Pistolesi C; Fanos V; Messori A; Martini N
    Dev Pharmacol Ther; 1993; 20(3-4):167-73. PubMed ID: 7828449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models.
    Labaune JM; Bleyzac N; Maire P; Jelliffe RW; Boutroy MJ; Aulagner G; Putet G
    Biol Neonate; 2001 Aug; 80(2):142-7. PubMed ID: 11509814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid compartmental pharmacokinetics of amikacin in neonates.
    Allegaert K; Scheers I; Adams E; Brajanoski G; Cossey V; Anderson BJ
    Antimicrob Agents Chemother; 2008 Jun; 52(6):1934-9. PubMed ID: 18378715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited predictability of amikacin clearance in extreme premature neonates at birth.
    Allegaert K; Anderson BJ; Cossey V; Holford NH
    Br J Clin Pharmacol; 2006 Jan; 61(1):39-48. PubMed ID: 16390350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic drug monitoring of amikacin in preterm and term infants.
    Siddiqi A; Khan DA; Khan FA; Razzaq A
    Singapore Med J; 2009 May; 50(5):486-9. PubMed ID: 19495517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between aminoglycoside pharmacokinetic parameters and patient's factors: from statement to implication for individual dosage design.
    Firsov AA; Nasonov VN
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():327-31. PubMed ID: 1820904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interindividual variability of aminoglycoside pharmacokinetics in preterm neonates at birth.
    Allegaert K; Anderson BJ
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1011-2. PubMed ID: 17006675
    [No Abstract]   [Full Text] [Related]  

  • 11. [The determination of pharmacokinetic parameters from surveillance protocols of sepsis therapy].
    von Hattingberg HM; Roos R; Brockmeier D; Marget W
    Internist (Berl); 1983 Mar; 24(3):162-6. PubMed ID: 6347942
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kinetics of multiple-dose amikacin in the newborn infant].
    Olivesi A; Camboulives J; Charrel C; Unal D
    Ann Anesthesiol Fr; 1981; 22(2):212-8. PubMed ID: 6115610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amikacin pharmacokinetics and suggested dosage modifications for the preterm infant.
    Kenyon CF; Knoppert DC; Lee SK; Vandenberghe HM; Chance GW
    Antimicrob Agents Chemother; 1990 Feb; 34(2):265-8. PubMed ID: 2327775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gestational age, birth weight, and hypoxemia on pharmacokinetics of amikacin in serum of infants.
    Myers MG; Roberts RJ; Mirhij NJ
    Antimicrob Agents Chemother; 1977 Jun; 11(6):1027-32. PubMed ID: 879747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommended amikacin doses in newborns often produce excessive serum levels.
    Philips JB; Satterwhite C; Dworsky ME; Cassady G
    Pediatr Pharmacol (New York); 1982; 2(2):121-5. PubMed ID: 12760404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation.
    Bleyzac N; Varnier V; Labaune JM; Corvaisier S; Maire P; Jelliffe RW; Putet G; Aulagner G
    Eur J Clin Pharmacol; 2001 Sep; 57(6-7):499-504. PubMed ID: 11699615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Individualization of the amikacin administration regimen on the basis of the relationship between its pharmacokinetics and the patient's status].
    Firsov AA; Nasonov VN; Murav'eva SA; Portnoĭ IuA; Savitskaia KI
    Antibiot Khimioter; 1990 Sep; 35(9):47-51. PubMed ID: 2275595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amikacin dosage in the preterm newborn.
    Want SV; Jones AK; Darrell JH
    J Antimicrob Chemother; 1979 Sep; 5(5):527-30. PubMed ID: 500515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amikacin in neonates: dosing recommendations should be based on both pharmacokinetics and dynamics.
    Allegaert K; Sherwin CM
    Singapore Med J; 2010 Jan; 51(1):88-9. PubMed ID: 20200782
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life.
    Allegaert K; Cossey V; Langhendries JP; Naulaers G; Vanhole C; Devlieger H; Van Overmeire B
    Biol Neonate; 2004; 86(3):207-11. PubMed ID: 15249757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.